Herbert Smith Freehills advises sponsors on Abbisko’s HK$1.754 billion Hong Kong IPO ??????????????????????????17.54???IPO??????
Herbert Smith Freehills
OCTOBER 14, 2021
"Abbisko is dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies and has strategically designed and developed a diversified pipeline of 12 programs with global R&D and commercialisation rights and selectively in-licensed two programs.". from 2025 to 2030. HK?????????06609.HK????????06669.HK??.
Let's personalize your content